The biotechnology and speciality drugs manufacturer Bristol-Myers Squibb (www.bms.com) has announced plans for a worldwide restructuring plan which would lead to a cut of 10% of it’s 43,000 worldwide workforce. This news comes after a rocky time in September this year when the CEO, Peter Dolan, was sacked amid investigations of wrong doings.
Bristol-Myers Squibb has been in Ireland since 1964 and has two operation plants in Dublin, one in Swords and another in Mulhuddart. There has not, as of yet, been any announcement of job looses in Ireland. But it is expected some of the 4,300 proposed cuts will be from their plants in Dublin.